We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+25.81%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$241M
AUM Growth
+$50.3M
(+26%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
4.88%
Top 10 Holdings %
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield Renewable
BEPC
|
+$1.51M |
| 2 |
Western Midstream Partners
WES
|
+$926K |
| 3 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$707K |
| 4 |
Delek US
DK
|
+$681K |
| 5 |
CVR Energy
CVI
|
+$669K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$1.61M |
| 2 |
AIMT
Aimmune Therapeutics
AIMT
|
+$1.13M |
| 3 |
AIV
Aimco
AIV
|
+$1.1M |
| 4 |
Telefônica Brasil
VIV
|
+$1.01M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$988K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.53% |
| 2 | Real Estate | 18.96% |
| 3 | Energy | 16.61% |
| 4 | Materials | 11.31% |
| 5 | Utilities | 7.08% |
Similar funds
AMIM
EFS
NCM
OC
LIWM
VFG
IAM
1M
Virtus ETF Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, Virtus ETF Advisers held 372 positions worth $241M, up 26% from $191M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Virtus ETF Advisers deployed $11.8M of net new capital in Q4 2020, opening 47 new positions and adding to 146 existing holdings. Its largest new stake was Harmony Biosciences: 14,899 shares worth $539K.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Amicus Therapeutics, an estimated $572K trimmed.
- Virtus ETF Advisers's largest Q4 2020 buy was Harmony Biosciences: 14,899 shares worth $539K.
- Virtus ETF Advisers added most to Brookfield Renewable in Q4 2020, an estimated $1.51M increase.
- Virtus ETF Advisers's biggest Q4 2020 reduction was Amicus Therapeutics, cutting an estimated $572K.
- Virtus ETF Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $1.61M.
- Virtus ETF Advisers's ten largest holdings make up 9.4% of its $241M portfolio in Q4 2020.
- Virtus ETF Advisers opened 47 new positions and closed 17 in Q4 2020.
- Virtus ETF Advisers's portfolio value rose 26% quarter-over-quarter to $241M.
Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.